SYN•benzinga•
Synthetic Biologics Announces Presentation On VCN-11, A Novel Oncolytic Adenovirus Designed To Evade Neutralizing Antibodies At The Upcoming 25th Annual Meeting Of The American Society Of Gene & Cell Therapy May 16-19
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 4, 2022 by benzinga